Zacks downgrades Novanta stock to Hold. Consensus target is USD 194.00.
Published on 10/17/2026 at 22:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and market position
- Zacks Research cut Novanta's rating from strong buy to hold in a note dated October 6, 2026, while the consensus target was USD 194.00.
- Novanta is scheduled to release third-quarter 2026 results after the market close on November 9, 2026.
- Novanta stock closed at USD 128.79 on October 16, 2026 at 4:00 p.m. ET, down 4.46 percent versus the Nasdaq prior close.
- Novanta had a price-to-earnings ratio of 82.56 and market capitalization of USD 4.9 billion.
Zacks Research downgraded Novanta from strong buy to hold in a note dated October 6, 2026, while the consensus target stood at USD 194.00, according to MarketBeat. The target was 50.64 percent above the USD 128.79 Nasdaq closing price. Novanta stock closed at USD 128.79 on October 16, 2026 at 4:00 p.m. ET, down 4.46 percent versus the Nasdaq prior close.
November 9 marks the next report
Novanta is scheduled to release its third-quarter 2026 results after the close of U.S. financial markets on November 9, 2026. The company will discuss the results in a conference call on November 10, 2026 at 8:00 a.m. ET, according to Business Wire.
Second-quarter revenue rose 10.30 percent
For the second quarter ended July 3, 2026, revenue reached USD 265.8 million, compared with USD 241.0 million in the year-earlier quarter. GAAP diluted earnings per share came to USD 0.30, versus USD 0.12 a year earlier, while operating income increased to USD 18.1 million from USD 14.9 million, according to Business Wire. The quarter provides the latest reported operating comparison before the November release.
Stock remains above its yearly low
The Nasdaq stock stood 31.06 percent above its 52-week low of USD 98.27 and 26.98 percent below its 52-week high of USD 176.38 on October 16, 2026. Trading volume was 240,639 shares, compared with an average volume of 403,015 shares.
Valuation and market value
Novanta had a market capitalization of USD 4.9 billion and a trailing price-to-earnings ratio of 82.56 on October 16, 2026. The valuation sits alongside the USD 194.00 consensus target cited by MarketBeat, but the next scheduled results remain the clearest dated event for the stock.
Comparison with peers
Novanta (Nasdaq, USD): minus 4.46 percent, price-to-earnings ratio 82.56, market capitalization USD 4.9 billion
Intuitive Surgical (Nasdaq, USD): minus 0.27 percent, price-to-earnings ratio 48.54, market capitalization USD 150.7 billion
ResMed (NYSE, USD): minus 1.35 percent, price-to-earnings ratio 22.98, market capitalization USD 33.6 billion
Price and upcoming results
Novanta's next report is scheduled for November 9, 2026, after the close of U.S. financial markets. The stock closed at USD 128.79 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 4.46 percent versus the prior Nasdaq close.
Market context: Market report S&P 500.
